Welcome To The Mannkind HUB On AGORACOM
Edit this title from the Fast Facts Section
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

INTERVIEW ALERT!!!

The Company George Calls "The Future Of Farming"

  • Urban Barns Foods
  • Now Entering Commercialization Phase
  • Tier-1 Clients = Commercial Acceptance
  • 40% Of Stock Owned By Dundee Capital
  • 24/7/365 Growing; Non-GMO; 94% LESS Water
  • On Their Way To California To Meet Ag Farmers
  • $5 Million Market Cap

WATCH THIS VIDEO AND DISCOVER A SMALL CAP STAR

Urban Barns Foods Is The Future Of Global Farming

Hub On AGORACOM / Corporate Profile / Watch Interview!

Message: MannKind Corporation to Present at The 31st Annual J.P. Morgan Healthcare Confer

Barney-fife-crop-fix
Rank: [?]
President
Points: [?]
5496
Rating: [?]
Votes: 21 Score: 4.5
  • Currently 4.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

MannKind Corporation to Present at The 31st Annual J.P. Morgan Healthcare Confer

posted on Jan 03, 13 05:39PM

MannKind Corporation to Present at The 31st Annual J.P. Morgan Healthcare Conference

VALENCIA, Calif.
BusinessWire

MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at The 31st Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2013 at 8:00 AM (PST) at St. Francis Hotel in San Francisco, California.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA®, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Contacts

MannKind Corporation
Matthew J. Pfeffer
Corporate Vice President and
Chief Financial Officer
661-775-5300 begin_of_the_skype_highlighting 661-775-5300 end_of_the_skype_highlighting
mpfeffer@mannkindcorp.com

© Copyright (c) Business Wire

http://www.vancouversun.com/mobile/business/businesswire/MannKind+Corporation+Present+31st+Annual+Morgan+Healthcare+Conference/7772440/story.html

New Message

Please login to post a reply

AGORACOM Quick Tips

Testimonials. Members Sure Love AGORACOM! ... Get On The List!

President's D.D.

Here's the latest Griffin report read more

Stock Quote

Hub Leaders